Azenkot T, Nikanjam M, Mhatre S, Mullen JT, et al. High dose interleukin-2 in combination with anti-programmed cell death protein 1 to overcome immune checkpoint inhibitor resistance in metastatic melanoma and renal cell carcinoma. Melanoma Res 2026 Apr 30. doi: 10.1097/CMR.0000000000001102.
PMID: 42070986